# JFL Life Scienc (NSE: JFLLIFE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/JFLLIFE · Pivot · prices to 22 Oct 2026

JFL Life Scienc (NSE: JFLLIFE) closed at ₹10.30 on 22 Oct 2026, down 4.63% on the day. With a market capitalisation of ₹34 Cr, it ranks 3302nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 0.2× trailing earnings, against a return on equity of 10.5% in FY25. Over the past year the share price has fallen 29.0%. Its 52-week range is ₹8.55 (30 Mar 2026) to ₹14.70 (24 Dec 2025); the last close is 29.9% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹63 Cr (+437.5% year on year) and net profit ₹2 Cr (+1,975.0%), on a standalone basis. Promoters held 67.47% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹10.30 |
| Market cap | ₹34 Cr |
| P/E (trailing) | 0.2 |
| ROE | 10.5% (FY25) |
| ROCE | 17.9% (FY25) |
| Debt to equity | 0.27 |
| 52-week high | ₹14.70 (24 Dec 2025) |
| 52-week low | ₹8.55 (30 Mar 2026) |
| 1-year return | −29.0% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹63 Cr | +437.5% | ₹2 Cr | +1,975.0% | ₹0.50 |
| Q3 FY26 | ₹27 Cr | +26.3% | ₹2 Cr | +173.0% | ₹0.61 |
| Q2 FY26 | ₹30 Cr | −24.3% | ₹2 Cr | +38.7% | ₹0.60 |
| Q1 FY26 | ₹12 Cr | +21.5% | ₹1 Cr | −60.7% | ₹0.23 |
| Q4 FY25 | ₹12 Cr | −42.1% | ₹0 Cr | −95.3% | ₹0.03 |
| Q3 FY25 | ₹21 Cr | +279.5% | ₹1 Cr | +155.2% | ₹0.22 |
| Q2 FY25 | ₹40 Cr | — | ₹1 Cr | — | ₹1.29 |
| Q1 FY25 | ₹10 Cr | — | ₹2 Cr | — | ₹1.74 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹82 Cr | ₹4 Cr |
| FY24 | ₹47 Cr | ₹3 Cr |
| FY23 | ₹43 Cr | ₹3 Cr |
| FY22 | ₹34 Cr | ₹3 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 67.47%
- Non-institutions: 32.53%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Roopa Ind](https://app.pivotnow.in/stock/ROOPAIND) | — | ₹38 Cr | — | — |
| [Lasa Supergenerics](https://app.pivotnow.in/stock/LASA) | — | ₹37 Cr | — | — |
| [Chandra Bhagat](https://app.pivotnow.in/stock/CBPL) | — | ₹33 Cr | — | — |
| [Sharma East Ind](https://app.pivotnow.in/stock/SHARMEH) | — | ₹33 Cr | — | — |
| [Deccan Health C](https://app.pivotnow.in/stock/DECCAN) | — | ₹32 Cr | — | — |
| [Medi-Caps](https://app.pivotnow.in/stock/MEDICAPQ) | ₹25.50 | ₹32 Cr | — | — |

## Questions and answers

### What is the share price of JFL Life Scienc today?

JFL Life Scienc (NSE: JFLLIFE) last closed at ₹10.30 on 22 Oct 2026. Its 52-week high is ₹14.70 and its 52-week low is ₹8.55.

### What is the market cap of JFL Life Scienc?

JFL Life Scienc's market capitalisation is ₹34 Cr (₹34 Cr) at the 22 Oct 2026 close, ranking 3302nd among the NSE companies Pivot tracks.

### What is the P/E ratio of JFL Life Scienc?

JFL Life Scienc trades at a trailing P/E of 0.2.

### What is the ROE and ROCE of JFL Life Scienc?

Return on equity was 10.5% in FY25 and return on capital employed was 17.9% in FY25 (standalone figures).

### Is JFL Life Scienc a debt-free company?

No. JFL Life Scienc's debt-to-equity ratio was 0.27 in FY25, with total debt of ₹0 Cr.

### What were JFL Life Scienc's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), JFL Life Scienc reported revenue of ₹63 Cr, +437.5% year on year, and net profit of ₹2 Cr, +1,975.0% year on year.

### How has JFL Life Scienc stock performed over the last year?

JFL Life Scienc's share price has fallen 29.0% over the past year, +2.0% over three months and +6.2% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of JFL Life Scienc?

As of 30 Jun 2026: promoters 67.47%, non-institutions 32.53%.

### Who are JFL Life Scienc's competitors?

The listed Pharma & Healthcare companies closest to JFL Life Scienc by market cap are Roopa Ind, Lasa Supergenerics, Chandra Bhagat, Sharma East Ind, Deccan Health C and Medi-Caps.

### Is JFL Life Scienc a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out JFL Life Scienc's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on JFLLIFE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.